AP6 has divested its stake in Asker Healthcare Group, a leading supplier of medical products and solutions in Europe. The profit for the investment amounts to just over SEK 4 billion.

AP6 invested in Asker Healthcare Group in 2019 together with the Ikea sphere investment company Nalka. AP6 has carried out this type of co-investments for over a decade and has built up solid specialist expertise in the area. The deal is a textbook example of the type of investment collaborations that AP6 seeks. The investment in Asker Healthcare Group has been very good for the pension savers in the Swedish state pension system.

Together with Nalka, AP6 invested 2019 in Asker Healthcare Group. In co-investments, AP6 takes the role of minority investor. The collaboration with Nalka, other co-investors and company management has worked excellently. Asker Healthcare Group has developed into a very successful company with strong value creation. During the time that AP6 has been a partner, the company has shown that it can professionally handle challenges such as the pandemic years and the subsequent inflationary pressure.

Since 2012, AP6 has been pursuing a successful investment strategy that has generated a high return for the AP fund system. The strategy is based on an international private equity portfolio of indirect investments in high-quality funds and co-investments. AP6’s co-investment strategy is focused on large and mid-sized companies. AP6 invests together with experienced and established financial players where there is a strong consensus on value creation and sustainability.